NGL Fine Chem starts Phase II production at Tarapur

The company had earlier intimated that Phase I of the Greenfield facility commenced commercial production with effect from March 11, 2025

Briefs: IOL Chemicals and Pharmaceuticals and Dr. Lal PathLabs

IOL Chemicals and Pharmaceuticals obtains EU-REACH registration for Triacetin

Precision Diabetes and DirectSens partner to launch MetMark AHB Test in the US

New research shows alpha-hydroxybutyrate can identify increased type 2 diabetes risk nearly a decade before diagnosis; DirectSens technology enables routine clinical chemistry testing

Roquette posts 9% H1 growth as transformation plan delivers early gains

The Health & Pharma Business Unit continued to face intense competition and pricing pressure

AstraZeneca commits $100m to youth health

Targets 10 million more young people by 2030

Bayer rolls out mono-PP blister for Talcid in Germany

Syrma Johari MedTech opens new medical plastics facility

The new 1.29 lakh sq. ft. facility integrates molding, extrusion, and cleanroom manufacturing, expanding SJML’s precision medical component and diagnostic capabilities

Recipharm and CanVirex partner to advance oncolytic virus therapy

The programme will establish a scalable manufacturing process for CanVirex's lead candidate, expressing IL-12, targeting advanced solid tumours

Envisagenics and Boehringer Ingelheim strike $1 billion-plus cancer drug collaboration

Under the agreement, Boehringer Ingelheim will evaluate selected targets identified through Envisagenics’ AI-powered SpliceCore platform

Enveda raises $311 million Series E to advance AI-driven drug pipeline

Enveda said the new capital will be used to move ENV-294 and ENV-308 into later-stage trials

Anton Paar India launches NEXUS to tackle industry’s toughest analytical challenges

The platform will combine expert perspectives and scientific insights with practical analytical approaches, live technology demonstrations and peer-to-peer discussions

Novartis bags $900 million global rights to BoomRay's preclinical radioligand asset

The partnership pairs BoomRay's early-stage precision oncology R&D with Novartis's established global scale in the radiopharmaceutical sector

Hovione doubles US spray-drying capacity With New Jersey expansion

Fredun Pharmaceuticals acquires 26% stake in Rs. 300 crore valued Goodman Vetcare

The companies will focus on geographic expansion and strengthening the brand's omnichannel footprint.

Eli Lilly begins construction on $6.5 billion Houston facility

New facility will manufacture active pharmaceutical ingredients for medicines like Foundayo (orforglipron), strengthening domestic supply chain

Hikal enters personal care market with new Panoli facility

The facility has commenced commercial production recently, and successfully manufactured its first production batches

Sartorius and NIBRT to launch global continuous bioprocessing training hub in Dublin

The Process Intensification Training Center in Dublin will provide hands-on training and knowledge-sharing for the biopharmaceutical industry

Real-world VRAYLAR studies show improvements in depression and quality of life

These prospective studies provide additional evidence that VRAYLAR can help patients achieve meaningful improvements in depressive symptoms, functioning and other patient-centered outcomes in routine clinical practice

Roche’s Ocrevus moves closer to EU nod for paediatric MS

The CHMP recommendation is based on results from the Phase III OPERETTA 2 study

ABITEC and Curapath fix strategic MoU to expand LNP delivery options

The partnership brings together capabilities spanning lipid excipients, shielding polymers, nanoformulation and cGMP manufacturing